Shandong Xinhua Pharmaceutical Co Ltd
SZSE:000756
Intrinsic Value
Shandong Xinhua Pharmaceutical Co Ltd is a CN-based company operating in Pharmaceuticals industry. [ Read More ]
The intrinsic value of one
Shandong Xinhua Pharmaceutical Co Ltd
stock under the Base Case scenario is
17.87
CNY.
Compared to the current market price of 16.95 CNY,
Shandong Xinhua Pharmaceutical Co Ltd
is
Undervalued by 5%.
Shandong Xinhua Pharmaceutical Co Ltd's market capitalization is 8.3B CNY.
Shandong Xinhua Pharmaceutical Co Ltd stock price is 16.95 CNY.
Shandong Xinhua Pharmaceutical Co Ltd stock price (16.95 CNY) is 5% less than its Intrinsic Value (17.87 CNY).
Shandong Xinhua Pharmaceutical Co Ltd stock (13.45 CNY) is 21% less than its price (16.95 CNY). Open DCF Valuation
Shandong Xinhua Pharmaceutical Co Ltd stock price (16.95 CNY) is 24% less than its Relative Value (22.29 CNY). Open Relative Valuation
Shandong Xinhua Pharmaceutical Co Ltd has downside potential of 18% compared to the average analyst price target.
Open Wall St Estimates
Shandong Xinhua Pharmaceutical Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 11%.
Shandong Xinhua Pharmaceutical Co Ltd has positive three-year average ROE (Return on Equity): 11%. The company is efficient at transforming stockholders' equity into net income.
Shandong Xinhua Pharmaceutical Co Ltd has positive Net Debt. This means that the company has more debt (2B CNY) than cash and short-term investments (922m CNY).
Shandong Xinhua Pharmaceutical Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 7%.
Shandong Xinhua Pharmaceutical Co Ltd's Revenue has dropped by 5% over the past 12 months.
Shandong Xinhua Pharmaceutical Co Ltd has positive Free Cash Flow for the last twelve months.
Shandong Xinhua Pharmaceutical Co Ltd has positive Operating Income for the last twelve months.
Shandong Xinhua Pharmaceutical Co Ltd has positive Net Income for the last twelve months.
Shandong Xinhua Pharmaceutical Co Ltd has positive three-year average ROIC (Return on Invested Capital): 7%. The company is efficient at using invested capital to generate operating income.
Shandong Xinhua Pharmaceutical Co Ltd's short-term assets (3B CNY) exceed its short-term liabilties (2B CNY).
Shandong Xinhua Pharmaceutical Co Ltd has positive Gross Profit for the last twelve months.
Shandong Xinhua Pharmaceutical Co Ltd's Altman Z-Score is very high and is equal to 3.03.
Shandong Xinhua Pharmaceutical Co Ltd's long-term assets (8B CNY) exceed its long-term liabilties (4B CNY).
Shandong Xinhua Pharmaceutical Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.33.
Valuation Backtest
Shandong Xinhua Pharmaceutical Co Ltd
Run backtest to discover the historical profit from buying and selling
Shandong Xinhua Pharmaceutical Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Shandong Xinhua Pharmaceutical Co Ltd
Balance Sheet Decomposition
Shandong Xinhua Pharmaceutical Co Ltd
| Current Assets | 3.5B |
| Cash & Short-Term Investments | 922.1m |
| Receivables | 1.3B |
| Other Current Assets | 1.3B |
| Non-Current Assets | 5B |
| Long-Term Investments | 276.7m |
| PP&E | 4.1B |
| Intangibles | 490.2m |
| Other Non-Current Assets | 150.4m |
| Current Liabilities | 2.4B |
| Accounts Payable | 643.2m |
| Accrued Liabilities | 91.3m |
| Short-Term Debt | 760.4m |
| Other Current Liabilities | 946.2m |
| Non-Current Liabilities | 1.3B |
| Long-Term Debt | 798.4m |
| Other Non-Current Liabilities | 463.6m |
Earnings Waterfall
Shandong Xinhua Pharmaceutical Co Ltd
|
Revenue
|
7.9B
CNY
|
|
Cost of Revenue
|
-5.8B
CNY
|
|
Gross Profit
|
2.2B
CNY
|
|
Operating Expenses
|
-1.7B
CNY
|
|
Operating Income
|
503.3m
CNY
|
|
Other Expenses
|
-16.5m
CNY
|
|
Net Income
|
486.8m
CNY
|
Free Cash Flow Analysis
Shandong Xinhua Pharmaceutical Co Ltd
Profitability Score
Profitability Due Diligence
Shandong Xinhua Pharmaceutical Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Shandong Xinhua Pharmaceutical Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Shandong Xinhua Pharmaceutical Co Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Score
Shandong Xinhua Pharmaceutical Co Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Shandong Xinhua Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
Shandong Xinhua Pharmaceutical Co Ltd
is 13.95 CNY
.
Shareholder Return
Price
Shandong Xinhua Pharmaceutical Co Ltd
| Average Annual Return | 57.17% |
| Standard Deviation of Annual Returns | 82.31% |
| Max Drawdown | -70% |
| Market Capitalization | 8.3B CNY |
| Shares Outstanding | 487 408 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Shandong Xinhua Pharmaceutical Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Shandong Xinhua Pharmaceutical Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zibo, Shandong and currently employs 6,533 full-time employees. SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED is a China-based company principally engaged in the development, production and distribution of chemical bulk drugs, preparations and medical intermediates. The Company’s main products include metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, L-dopa, pipemidic acid tablets, compound liquorice tablets and nimodipine tablets. The firm distributes its products in domestic market and to overseas markets, including the Americas, Europe and others.
Contact
IPO
Employees
Officers
The intrinsic value of one
Shandong Xinhua Pharmaceutical Co Ltd
stock under the Base Case scenario is
17.87
CNY.
Compared to the current market price of 16.95 CNY,
Shandong Xinhua Pharmaceutical Co Ltd
is
Undervalued by 5%.
You don't have any saved screeners yet
